Amylyx Pharmaceuticals raised $135M Series C venture round, led by Viking Global Investors.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Hedge Fund | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Hedge Fund | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Belinda Termeer |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$171.9M
Top Valuation
-
Amylyx Pharmaceuticals raised $135M in a Series C round.
The round was announced on 07/20/21.
The round was led by Viking Global Investors.